'Ready for Edibles' addresses safe storage,
responsible consumption, and differences in cannabis
products
EDMONTON, Oct. 30, 2019 /CNW/ - Aurora Cannabis Inc.
("Aurora") (NYSE | TSX: ACB), the Canadian company defining the
future of cannabis worldwide, today announced the launch of
Ready for Edibles, a national bilingual campaign
dedicated to educating new and experienced cannabis consumers on
responsible consumption and safe storage of edibles products before
they become available for sale in December.
In the visual style of Not Safe For Work (NSFW)¸the
campaign creative will depict blurred images of cookies, gummies
and other edibles products stamped with the wording: ADULTS ONLY,
stating "Edibles are coming and they're not for kids. Ask a
budtender or learn more at www.readyforedibles.com"
The campaign can be seen at cannabis retail outlets across
Canada and will be complemented
online with digital and video assets as well as radio, television
and out-of-home opportunities.
"The roll-out of Aurora's next generation of high-quality
cannabis products is very exciting and we are proud to be able to
offer new forms like vapes, concentrates and edibles," said
Terry Booth, CEO of Aurora. "We want
to make sure consumers have the information they need to understand
the differences in these products, how to consume them responsibly,
and most importantly, that they should be kept away from children
and pets."
Educational content will also focus on identifying signs of
over-consumption, understanding the differences in onset times and
effects, cautions around mixing with alcohol and driving while
intoxicated. All of Aurora's NextGen cannabis products,
including cookies, gummies, chocolates and mints, will include the
certified, lab-tested concentration of THC and CBD.
Check out the campaign creative attached to this release.
Before you get started with edibles, prepare yourself by
learning how to consume safely. Visit
www.readyforedibles.com to learn more.
About Aurora
Headquartered in Edmonton, Alberta,
Canada with funded capacity in excess of 625,000 kg per
annum and sales and operations in 25 countries across five
continents, Aurora is one of the world's largest and leading
cannabis companies. Aurora is vertically integrated and
horizontally diversified across every key segment of the value
chain, from facility engineering and design to cannabis breeding
and genetics research, cannabis and hemp production, derivatives,
high value-add product development, home cultivation, wholesale and
retail distribution.
Highly differentiated from its peers, Aurora has established a
uniquely advanced, consistent and efficient production strategy,
based on purpose-built facilities that integrate leading-edge
technologies across all processes, defined by extensive automation
and customization, resulting in the massive scale production of
high-quality consistent product. Designed to be replicable and
scalable globally, our production facilities are designed to
produce cannabis at significant scale, with high quality,
industry-leading yields, and low-per gram production costs. Each of
Aurora's facilities is built to meet European Union Good
Manufacturing Practices ("EU GMP") standards. Certification has
been granted to Aurora's first production facility in Mountain View
County, the MedReleaf Markham facility, and its wholly owned
European medical cannabis distributor Aurora Deutschland. All
Aurora facilities are designed and built to the EU GMP
standard.
In addition to the Company's rapid organic growth and strong
execution on strategic M&A, which to date includes 17 wholly
owned subsidiary companies – MedReleaf, CanvasRX, Peloton
Pharmaceutical, Aurora Deutschland, H2 Biopharma, BC Northern
Lights, Larssen Greenhouses, CanniMed Therapeutics, Anandia,
HotHouse Consulting, MED Colombia, Agropro, Borela, ICC Labs,
Whistler, Chemi Pharmaceutical, and Hempco – Aurora is
distinguished by its reputation as a partner and employer of choice
in the global cannabis sector, having invested in and established
strategic partnerships with a range of leading innovators,
including: Radient Technologies Inc. (TSXV: RTI), Cann Group Ltd.
(ASX: CAN), Micron Waste Technologies Inc. (CSE: MWM), Choom
Holdings Inc. (CSE: CHOO), CTT Pharmaceuticals (OTCC: CTTH),
Alcanna Inc. (TSX: CLIQ), High Tide Inc. (CSE: HITI), EnWave
Corporation (TSXV: ENW), Capcium Inc. (private), Evio Beauty Group
(private), and Wagner Dimas (private).
Aurora's Common Shares trade on the TSX and NYSE under the
symbol "ACB", and is a constituent of the S&P/TSX Composite
Index.
For more information about Aurora, please visit our investor
website, investor.auroramj.com
Terry Booth, CEO
Aurora Cannabis Inc.
SOURCE Aurora Cannabis Inc.